or Try an Advanced Search...

    ETF Components for SPEU - SPDR Portfolio Europe ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    NVO B 2.52 3.69
    NVS A 1.26 1.73

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Animal Health Anti Diabetic Drugs Antibiotics Biopharmaceutical Biotechnology Blood Test Contact Lens Contact Lenses Diabetes Diabetes Care Diagnostic Products Disposable Product Disposable Products Drugs Endocrine System Eye Eye Care Eye Care Products Eyewear
    Industries: Biotechnology Drug Manufacturers - Major

    Recent News for SPDR Portfolio Europe ETF & its Holdings

    Date Stock Title
    Jul 5 NVO Study links GLP-1 drugs, metformin to lower risk of certain cancers
    Jul 5 NVO Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
    Jul 5 NVS Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code
    Jul 5 NVO Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code
    Jul 5 NVO Novo Nordisk reprimanded in UK for failure to disclose payments to healthcare sector
    Jul 5 NVS What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
    Jul 5 NVO Is It Too Late to Buy Novo Nordisk Stock?
    Jul 5 NVO Did Vertex Pharmaceuticals Just Invent the Next Ozempic?
    Jul 4 NVO Novo Nordisk: Buy On Dips
    Jul 4 NVO NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
    Jul 3 NVO S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
    Jul 3 NVO Using Obesity Drugs? Potential Vision Loss Disorder Linked To Novo Nordisk's Ozempic And Wegovy, Study Finds
    Jul 3 NVO Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
    Jul 3 NVO Weight-loss drugs linked to rare vision loss: Harvard study
    Jul 3 NVO Update: Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
    Jul 3 NVO Novo Nordisk’s Ozempic, Wegovy linked to eye disorder in small study
    Jul 3 NVO Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
    Jul 3 NVO Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
    Jul 3 NVO Should You Hold Novo Nordisk A/S (NVO) for the Long Term?
    Jul 2 NVO Novo Nordisk and Eli Lilly Slide as Biden Blasts Weight-Loss Drug Prices
    The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the STOXX® Europe Total Market Index. Under normal market conditions, the fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. It employs a sampling strategy, which means that the fund is not required to purchase all of the securities represented in the index. The index is a free-float market capitalization weighted index designed to provide a broad representation of publicly traded Western European companies.
    Exchange Traded Fund Index Fund Stoxx
    Back to the Main SPEU Page...